Didanosine Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 125 mg, 200 mg, 250 mg, 400 mg
Reference Brands: Videx EC®
Category:
Anti Viral
Didanosine Capsules (Videx EC®) are delayed-release antiretrovirals for HIV-1, classified as NRTIs. Though used less today, they remain available via PharmaB2B platforms for legacy treatment needs. Sourced from WHO-GMP-approved suppliers, they suit NGOs and public health procurement looking for dependable ARV access.
Didanosine is available in Capsules
and strengths such as 125 mg, 200 mg, 250 mg, 400 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Didanosine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Didanosine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Didanosine Capsules, also known by the brand name Videx EC®, are delayed-release antiretroviral medications used in the treatment of HIV-1 infection. Belonging to the Nucleoside Reverse Transcriptase Inhibitor (NRTI) class, Didanosine works by blocking viral replication and is used in combination therapy. Though less commonly prescribed today due to newer alternatives, Didanosine remains relevant in specific treatment regimens and legacy programs. On PharmaB2B platforms, buyers can source WHO-GMP and USFDA-approved formulations in bulk from reliable manufacturers. Ideal for NGOs, tenders, and public sector supply chains in regions where Didanosine is still included in HIV treatment protocols.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing